Cargando…
In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes
BACKGROUND: Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most common inherited disorder of the mitochondrial fatty acid oxidation, caused by mutations in the ACADM gene. Since the introduction of neonatal screening for MCAD deficiency, a subgroup of newborns have been identified with...
Autores principales: | Touw, Catharina ML, Smit, G Peter A, Niezen-Koning, Klary E, Boer, Conny Bosgraaf-de, Gerding, Albert, Reijngoud, Dirk-Jan, Derks, Terry GJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610156/ https://www.ncbi.nlm.nih.gov/pubmed/23509891 http://dx.doi.org/10.1186/1750-1172-8-43 |
Ejemplares similares
-
Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study
por: Touw, Catharina M L, et al.
Publicado: (2012) -
Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients
por: Odendaal, Christoff, et al.
Publicado: (2023) -
Transcriptome analysis suggests a compensatory role of the cofactors coenzyme A and NAD(+) in medium-chain acyl-CoA dehydrogenase knockout mice
por: Martines, Anne-Claire M. F., et al.
Publicado: (2019) -
Plasma carnitine concentrations in Medium‐chain acyl‐CoA dehydrogenase deficiency: lessons from an observational cohort study
por: Jager, Emmalie A., et al.
Publicado: (2022) -
Medium‐chain Acyl‐COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment
por: Mason, Emily, et al.
Publicado: (2022)